BOULDER, Colo., Jan. 2, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
|
Event: |
Annual J.P. Morgan Healthcare Conference |
|
Presenter: |
Ron Squarer, Chief Executive Officer, Array BioPharma |
|
Date: |
Monday, January 8, 2018 |
|
Time: |
4:00 p.m. Pacific Time |
|
Location: |
Westin St. Francis Hotel, San Francisco |
|
Webcast: |
http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-calendar |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).
|
CONTACT: |
Tricia Haugeto |
|
Array BioPharma Inc. | |
|
303-386-1193 | |
SOURCE Array BioPharma Inc.